Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Thu, 12.10.2023       Valneva

First Berlin Equity Research has published a research update on Valneva SE (ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 8.90 price target. Abstract: Both Q2/23 revenues and adjusted EBITDA were above our and consensus forecasts and management has reiterated full-year product revenue guidance of &e [ … ]
Mon, 09.10.2023       ad pepper media International N.V.

First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 3,50. Zusammenfassung: Vergangene Woche haben ad pepper media (APM) und sieben Gesellschafter der sol [ … ]
Fri, 06.10.2023       Diversified Energy PLC

First Berlin Equity Research has published a research update on Diversified Energy PLC (ISIN: GB00BYX7JT74). Analyst Simon Scholes reiterated his BUY rating and maintained his GBp 180.00 price target. Abstract: DEC's share price has been hit hard during the recent period of market volatility. Yesterday morning management commented that they are [ … ]
Thu, 28.09.2023       M1 Kliniken AG

First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 10,50 auf EUR 11,90. Zusammenfassung: Der Halbjahresbericht zeichnete sich durch ein besonders starkes Ergebnis im Segment Beauty aus. Ange [ … ]
Wed, 27.09.2023       urban-gro, Inc

First Berlin Equity Research hat ein Research Update zu urban-gro, Inc. (ISIN: US91704K2024) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von USD 6,40. Zusammenfassung: Die Nachrichtenlage für urban-gro war in diesem Sommer ermutigend. Das Unternehmen schloss in diesem Monat [ … ]
Tue, 26.09.2023       Schloss Wacheneheim AG

First Berlin Equity Research has published a research update on Schloss Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 22.00 price target. Abstract: Final results for the year ending 30 June showed a 10.9% increase in sales to €425.8m (2021/22: €384.0m) and a 6.2% decline in  [ … ]
Wed, 20.09.2023       Knaus Tabbert AG

First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 83,00 auf EUR 86,00. Zusammenfassung: Das Management von Knaus Tabbert erhöhte die Prognose für 2023 aufgrund der verbesserten  [ … ]
Tue, 19.09.2023       Diversified Energy PLC

First Berlin Equity Research has published a research update on Diversified Energy PLC (ISIN: GB00BYX7JT74). Analyst Simon Scholes reiterated his BUY rating and maintained his GBp 180.00 price target. Abstract: H1/23 results once again demonstrated the effectiveness of DEC's business model in delivering high profits irrespective of the level of [ … ]
Mon, 18.09.2023       PAION AG

First Berlin Equity Research has published a research update on PAION AG (ISIN: DE000A0B65S3). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 38.00 to EUR 11.00. Abstract: PAION's lead product remimazolam was first approved in January 2020 in Japan in the indication general anesthesia (GA). It has since  [ … ]
Mon, 18.09.2023       Haemato AG

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00. Zusammenfassung: Das Sechsmonatsbericht lag nahe an unseren Prognosen und verdeutlichte die schlankere operative Kostenstr [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 22.11.2024, Calendar Week 47, 327th day of the year, 39 days remaining until EoY.